Medizinische Fakultät

 

23.02.2012

Junior Debiopharm Life Sciences Awards 2012

Debiopharm Award 2012

The Sponsor, Debiopharm Group, is a Swiss biopharmaceutical company with a focus on the development of innovative therapies that target unmet medical needs.

The awards will honor two young researchers (postdocs or junior group leaders) under the age of 33 working at a Swiss institution in the wider area of Cellular and Molecular Biology.

This includes, but is not limited to cancer, genetics, signal transduction, infection biology, developmental biology, and neuroscience.

The awards consist of a total of 25'000 CHF each, of which one fifth is a personal award, while the rest will contribute to support the awardee's research. It will be presented at the Annual EPFL Life Science Symposium "Global Health meets Infection Biology" to be held 29-31 August 2012 (for more information please visit http://lss2012.epfl.ch/).

Candidates are invited to submit their applications no later than April 15th, 2011. A Jury of internationally renowned scientific experts will evaluate the applications, and invite preselected candidates to the EPFL for a short presentation. The dossier should be comprised of:

1. her/his curriculum vitae,

2. her/his list of publications,

3. a one-page outline of her/his plans for future research and career,

4. names and contact details of two reference persons.

All dossiers are to be sent, exclusively in electronic format and in the form of one single pdf file, to: harald.hirling@epfl.ch

Jeannette Roka

News

Weitere News